Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Signos Inc
The scope of this study is to enroll existing and new Signos users in a volunteer study that utilizes a continuous glucose monitor (CGM) and mobile health application \[Signos\] to optimize general wellness and body weight and composition. This is a no more than minimal risk study.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
18 years and above
Own a smartphone and be willing to install the Signos App to use the app, receive messages or notifications, and input weight and other data.
Willingness to complete questionaries or other surveys
Able to speak and read English
You may not be if
Medical diagnosis of Type 1 Diabetes
Medical diagnosis of Type 2 Diabetes
Current medical diagnosis of an eating disorder (anorexia or bulimia) or previously struggled with disordered eating behaviors with current BMI less than 24
Medical conditions (e.g., such as seizure disorder) requiring a specific medical diet.
Inborn errors of metabolism such as phenylketonuria (PKU), glycogen storage disease, fructose intolerance, Maple Sugar Urine Disease (MSUD).
Chronic or severe disease (e.g, chronic obstructive pulmonary disease \[COPD\], coronary artery disease, cerebrovascular accident \[CVA\], or cardiac arrhythmia) that would preclude a subject from safely participating in dietary recommendations and/or physical activity
History of Gastric bypass or other bariatric surgery
History of 10 or more soft tissue skin infections (such as cellulitis or abscesses)
Intolerable skin reaction from adhesive
Currently taking any of the following medications: Hydroxyurea, insulin, sulfonylureas, or medications prescribed specifically for the treatment of diagnosed diabetes
Vulnerable populations such as minors, prisoners, or pregnant women will not be enrolled in this study. Women who become pregnant will be excluded at that time.
Inability or unwillingness of subject to give informed consent
Clareo Health | Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
